Global Urological Cancer Therapeutics Drugs Market Analysis 2013-2018 and Forecast 2019-2024

Date : May 2019

Formats :
Report Code : PMR93926275

Category : Medical Devices
No Of Pages : 104

Urological Cancer Therapeutics Drugs Market Analysis

Snapshot
The global Urological Cancer Therapeutics Drugs market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Urological Cancer Therapeutics Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage Market Size & Forecast, Major Company of Product Type etc. :
Xofigo radium Ra 223 dichloride
Jevtana cabazitaxel
Inlyta axitinib
Votrient pazopanib hydrochloride
Sutent sunitinib malate
Zytiga abiraterone acetate
Xtandi enzalutamide
Opdivo nivolumab
Provenge sipuleucel-T
Company Coverage Sales Revenue, Price, Gross Margin, Main Products etc. :
Novartis
Pfizer
Johnson & Johnson
AstraZeneca
Astellas
Bristol-Myers Squibb
Abbott Laboratories
Celgene Corporation
Dendreon Corporation
Ferring Pharmaceuticals
GlaxoSmithKline plc
Indevus Pharmaceuticals Inc
Ipsen
Roche Healthcare
Sanofi S.A.
Application Coverage Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc. :
Hospital
Medical Research Laboratory
Others
Region Coverage Regional Production, Demand & Forecast by Countries etc. :
North America U.S., Canada, Mexico
Europe Germany, U.K., France, Italy, Russia, Spain etc.
Asia-Pacific China, India, Japan, Southeast Asia etc.
South America Brazil, Argentina etc.
Middle East & Africa Saudi Arabia, South Africa etc.
Table of Contents

1 Industry Overview
1.1 Urological Cancer Therapeutics Drugs Industry
1.1.1 Overview
1.1.2 Development of Urological Cancer Therapeutics Drugs
1.2 Market Segment
1.2.1 Upstream
1.2.2 Downstream
1.3 Cost Analysis
2 Industry Environment PEST Analysis
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Urological Cancer Therapeutics Drugs Market by Type
3.1 By Type
3.1.1 Xofigo radium Ra 223 dichloride
3.1.2 Jevtana cabazitaxel
3.1.3 Inlyta axitinib
3.1.4 Votrient pazopanib hydrochloride
3.1.5 Sutent sunitinib malate
3.1.6 Zytiga abiraterone acetate
3.1.7 Xtandi enzalutamide
3.1.8 Opdivo nivolumab
3.1.9 Provenge sipuleucel-T
3.2 Market Size
3.3 Market Forecast
4 Major Companies List
4.Urological Cancer Therapeutics Drugs Novartis Company Profile, Sales Data etc.
4.2 Pfizer Company Profile, Sales Data etc.
4.3 Johnson & Johnson Company Profile, Sales Data etc.
4.4 AstraZeneca Company Profile, Sales Data etc.
4.5 Astellas Company Profile, Sales Data etc.
4.6 Bristol-Myers Squibb Company Profile, Sales Data etc.
4.7 Abbott Laboratories Company Profile, Sales Data etc.
4.8 Celgene Corporation Company Profile, Sales Data etc.
4.9 Dendreon Corporation Company Profile, Sales Data etc.
4.10 Ferring Pharmaceuticals Company Profile, Sales Data etc.
4.11 GlaxoSmithKline plc Company Profile, Sales Data etc.
4.12 Indevus Pharmaceuticals Inc Company Profile, Sales Data etc.
4.13 Ipsen Company Profile, Sales Data etc.
4.14 Roche Healthcare Company Profile, Sales Data etc.
4.15 Sanofi S.A. Company Profile, Sales Data etc.
5 Market Competition
5.1 Company Competition
5.2 Regional Market by Company
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital
6.1.2 Demand in Medical Research Laboratory
6.1.3 Demand in Others
6.2 Regional Demand Comparison
6.3 Demand Forecast
7 Region Operation
7.1 Regional Production
7.2 Regional Market
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
7.3.1.2 by Country U.S., Canada, Mexico
7.3.2 Europe
7.3.2.1 Overview
7.3.2.2 by Country Germany, U.K., France, Italy, Russia, Spain etc.
7.3.3 Asia-Pacific
7.3.3.1 Overview
7.3.3.2 by Country China, India, Japan, Southeast Asia etc.
7.3.4 South America
7.3.4.1 Overview
7.3.4.2 by Country Brazil, Argentina etc.
7.3.5 Middle East & Africa
7.3.5.1 Overview
7.3.5.2 by Country Saudi Arabia, South Africa etc.
7.4 Regional Import & Export
7.5 Regional Forecast
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
9 Research Conclusion
Table Upstream Segment of Urological Cancer Therapeutics Drugs
Table Application Segment of Urological Cancer Therapeutics Drugs
Table Global Urological Cancer Therapeutics Drugs Market 2013-2024, by Application, in USD Million
Table Major Company List of Xofigo (radium Ra 223 dichloride)
Table Major Company List of Jevtana (cabazitaxel)
Table Major Company List of Inlyta (axitinib)
Table Major Company List of Votrient (pazopanib hydrochloride)
Table Major Company List of Sutent (sunitinib malate)
Table Major Company List of Zytiga (abiraterone acetate)
Table Major Company List of Xtandi (enzalutamide)
Table Major Company List of Opdivo (nivolumab)
Table Major Company List of Provenge (sipuleucel-T)
Table Global Urological Cancer Therapeutics Drugs Market 2013-2018, by Type, in USD Million
Table Global Urological Cancer Therapeutics Drugs Market 2013-2018, by Type, in Volume
Table Global Urological Cancer Therapeutics Drugs Market Forecast 2019-2024, by Type, in USD Million
Table Global Urological Cancer Therapeutics Drugs Market Forecast 2019-2024, by Type, in Volume
Table Novartis Overview List
Table Urological Cancer Therapeutics Drugs Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Urological Cancer Therapeutics Drugs Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Urological Cancer Therapeutics Drugs Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Urological Cancer Therapeutics Drugs Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astellas Overview List
Table Urological Cancer Therapeutics Drugs Business Operation of Astellas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Urological Cancer Therapeutics Drugs Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbott Laboratories Overview List
Table Urological Cancer Therapeutics Drugs Business Operation of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Corporation Overview List
Table Urological Cancer Therapeutics Drugs Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dendreon Corporation Overview List
Table Urological Cancer Therapeutics Drugs Business Operation of Dendreon Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ferring Pharmaceuticals Overview List
Table Urological Cancer Therapeutics Drugs Business Operation of Ferring Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline plc Overview List
Table Urological Cancer Therapeutics Drugs Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Indevus Pharmaceuticals Inc Overview List
Table Urological Cancer Therapeutics Drugs Business Operation of Indevus Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ipsen Overview List
Table Urological Cancer Therapeutics Drugs Business Operation of Ipsen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Healthcare Overview List
Table Urological Cancer Therapeutics Drugs Business Operation of Roche Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi S.A. Overview List
Table Urological Cancer Therapeutics Drugs Business Operation of Sanofi S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Urological Cancer Therapeutics Drugs Sales Revenue 2013-2018, by Company, in USD Million
Table Global Urological Cancer Therapeutics Drugs Sales Revenue Share, by Company, in USD Million
Table Global Urological Cancer Therapeutics Drugs Sales Volume 2013-2018, by Company, in Volume
Table Global Urological Cancer Therapeutics Drugs Sales Volume Share 2013-2018, by Company, in Volume
Table Major Consumers List and Overview
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Urological Cancer Therapeutics Drugs Demand Forecast 2019-2024, by Application, in USD Million
Table Urological Cancer Therapeutics Drugs Demand Forecast 2019-2024, by Application, in Volume
Table Urological Cancer Therapeutics Drugs Production 2013-2018, by Region, in USD Million
Table Urological Cancer Therapeutics Drugs Production 2013-2018, by Region, in Volume
Table Global Urological Cancer Therapeutics Drugs Market 2013-2018, by Region, in USD Million
Table Global Urological Cancer Therapeutics Drugs Market Share 2013-2018, by Region, in USD Million
Table Global Urological Cancer Therapeutics Drugs Market 2013-2018, by Region, in Volume
Table Global Urological Cancer Therapeutics Drugs Market Share 2013-2018, by Region, in Volume
Table North America Urological Cancer Therapeutics Drugs Market Size 2013-2018, by Country, in USD Million
Table North America Urological Cancer Therapeutics Drugs Market Size 2013-2018, by Country, in Volume
Table Europe Urological Cancer Therapeutics Drugs Market Size 2013-2018, by Country, in USD Million
Table Europe Urological Cancer Therapeutics Drugs Market Size 2013-2018, by Country, in Volume
Table Asia-Pacific Urological Cancer Therapeutics Drugs Market Size 2013-2018, by Country, in USD Million
Table Asia-Pacific Urological Cancer Therapeutics Drugs Market Size 2013-2018, by Country, in Volume
Table South America Urological Cancer Therapeutics Drugs Market Size 2013-2018, by Country, in USD Million
Table South America Urological Cancer Therapeutics Drugs Market Size 2013-2018, by Country, in Volume
Table Middle East & Africa Urological Cancer Therapeutics Drugs Market Size 2013-2018, by Country, in USD Million
Table Middle East & Africa Urological Cancer Therapeutics Drugs Market Size 2013-2018, by Country, in Volume
Table Urological Cancer Therapeutics Drugs Market Forecast 2019-2024, by Region, in USD Million
Table Urological Cancer Therapeutics Drugs Market Forecast 2019-2024, by Region, in Volume
Table Price Factors List

Figure Global Urological Cancer Therapeutics Drugs Market Growth 2013-2018, by Type, in USD Million
Figure Global Urological Cancer Therapeutics Drugs Market Growth 2013-2018, by Type, in Volume
Figure North America Urological Cancer Therapeutics Drugs Market Concentration, in 2018
Figure Europe Urological Cancer Therapeutics Drugs Market Market Concentration, in 2018
Figure Asia-Pacific Urological Cancer Therapeutics Drugs MMarket Concentration, in 2018
Figure South America Urological Cancer Therapeutics Drugs Market Concentration, in 2018
Figure Middle East & Africa Urological Cancer Therapeutics Drugs Market Concentration, in 2018
Figure Urological Cancer Therapeutics Drugs Demand in Hospital, 2013-2018, in USD Million
Figure Urological Cancer Therapeutics Drugs Demand in Hospital, 2013-2018, in Volume
Figure Urological Cancer Therapeutics Drugs Demand in Medical Research Laboratory, 2013-2018, in USD Million
Figure Urological Cancer Therapeutics Drugs Demand in Medical Research Laboratory, 2013-2018, in Volume
Figure Urological Cancer Therapeutics Drugs Demand in Others, 2013-2018, in USD Million
Figure Urological Cancer Therapeutics Drugs Demand in Others, 2013-2018, in Volume
Figure North America Urological Cancer Therapeutics Drugs Market Size and Growth 2013-2018, in USD Million
Figure North America Urological Cancer Therapeutics Drugs Market Size and Growth 2013-2018, in Volume
Figure Europe Urological Cancer Therapeutics Drugs Market Size and Growth 2013-2018, in USD Million
Figure Europe Urological Cancer Therapeutics Drugs Market Size and Growth 2013-2018, in Volume
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Market Size and Growth 2013-2018, in USD Million
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Market Size and Growth 2013-2018, in Volume
Figure South America Urological Cancer Therapeutics Drugs Market Size and Growth 2013-2018, in USD Million
Figure South America Urological Cancer Therapeutics Drugs Market Size and Growth 2013-2018, in Volume
Figure Middle East & Africa Urological Cancer Therapeutics Drugs Market Size and Growth 2013-2018, in USD Million
Figure Middle East & Africa Urological Cancer Therapeutics Drugs Market Size and Growth 2013-2018, in Volume
Figure Marketing Channels Overview
  Purchase Options for Report

Need More information

Call us :
USA : +1 7162260907
UK : +44 7441952057
....
sales@planetmarketreports.com

Why to PMR

PMR Market Research

Our syndicated research reports cover 50+ industry sectors offering you product and country wise breakup of the market along with niche data and insights that will help you make informed business decision. Our research is focused on the key segments of an industry that possess opportunities of growth.

  • Industrial ...
  • Business ....
  • Consumer ....
  • Peer ....

About Report

Planet Market Reports added Latest and detailed market study report that focuses on “Global Urological Cancer Therapeutics Drugs Market" Which offers essential information based on fresh ideas into Global Urological Cancer Therapeutics Drugs Market industry along with unique market analysis which covers current top Manufactures in Global Urological Cancer Therapeutics Drugs Market, growth, Consumption Demand, challenges, Historical data, subjects wise Survey of each chapters, Regional Insights, and Advancing industry trends, which will help our clients to aim Global Urological Cancer Therapeutics Drugs Market. In addition, the report helps the customers to get a brief idea about Future demand and specifications of products which ensures the driving long-term income and productivity of global market.